# Recombinant Human Prolactin for Lactation Induction

> **NCT00181623** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 6 (actual)

## Conditions studied

- Lactation

## Interventions

- **DRUG:** Recombinant Human Prolactin

## Key facts

- **NCT ID:** NCT00181623
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181623, "Recombinant Human Prolactin for Lactation Induction". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00181623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*